Chapter 12, Episode 50

This episode begins the discussion of specific antimicrobial drug classes, organized by mechanism of action. It starts with the historical development of Salvarsan and penicillin, then focuses on beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, which inhibit cell wall synthesis and are bactericidal. It also introduces resistance mechanisms like beta-lactamase and combination drugs like Augmentin. The episode then transitions to protein synthesis inhibitors, including tetracyclines, aminoglycosides, and macrolides, highlighting their targets, clinical uses, and key differences such as bacteriostatic vs. bactericidal effects.